Prostate cancer: natural history and surgical treatment of localised disease.

[1]  Hugh H. Young,et al.  The early diagnosis and radical cure of carcinoma of the prostate. Being a study of 40 cases and presentation of a radical operation which was carried out in four cases , 2002 .

[2]  H. D. de Koning,et al.  Health-related quality-of-life effects of radical prostatectomy and primary radiotherapy for screen-detected or clinically diagnosed localized prostate cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[3]  G. Bakale,et al.  Multicenter ProstaScint imaging findings in 2154 patients with prostate cancer. The ProstaScint Imaging Centers. , 2000, Urology.

[4]  B. Guillonneau,et al.  Laparoscopic radical prostatectomy: the Montsouris technique. , 2000, The Journal of urology.

[5]  P. Walsh,et al.  Radical prostatectomy for localized prostate cancer provides durable cancer control with excellent quality of life: a structured debate. , 2000, The Journal of urology.

[6]  D. Gunnell,et al.  Comparison of trends in prostate-cancer mortality in England and Wales and the USA , 2000, The Lancet.

[7]  J. Hanley,et al.  The positive yield of imaging studies in the evaluation of men with newly diagnosed prostate cancer: a population based analysis. , 2000, The Journal of urology.

[8]  H. D. de Koning,et al.  Prostate cancer detection at low prostate specific antigen. , 2000, The Journal of urology.

[9]  T. Wilt,et al.  Epidemiology of High-Grade Prostatic Intraepithelial Neoplasia , 2000, Scandinavian journal of urology and nephrology. Supplementum.

[10]  F. Iber.  Oxford Textbook of Clinical Hepatology, vols 1 & 2 , 1999 .

[11]  S. Fosså,et al.  Defining an international research agenda for quality of life in men with prostate cancer , 1999, The Prostate.

[12]  E. Feuer,et al.  Cancer surveillance series: interpreting trends in prostate cancer--part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. , 1999, Journal of the National Cancer Institute.

[13]  A W Partin,et al.  Natural history of progression after PSA elevation following radical prostatectomy. , 1999, JAMA.

[14]  W. Kirkels,et al.  The changing pattern of prostate cancer at the time of diagnosis: characteristics of screen detected prostate cancer in a population based screening study. , 1999, The Journal of urology.

[15]  S B Malkowicz,et al.  Biochemical Outcome After Radical Prostatectomy , External Beam Radiation Therapy , or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer , 2000 .

[16]  M. Toublanc,et al.  Radical prostatectomy for prostate cancer: the perineal approach increases the risk of surgically induced positive margins and capsular incisions. , 1998, The Journal of urology.

[17]  J. Hanley,et al.  Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer , 1998 .

[18]  M. Manyak,et al.  (111) INDIUM-CAPROMAB PENDETIDE IN THE EVALUATION OF PATIENTS WITH RESIDUAL OR RECURRENT PROSTATE CANCER AFTER RADICAL PROSTATECTOMY , 1998 .

[19]  B. Turnbull,et al.  Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial. , 1998, British journal of urology.

[20]  S. Ripatti,et al.  Prostate cancer and supplementation with alpha-tocopherol and beta-carotene: incidence and mortality in a controlled trial. , 1998, Journal of the National Cancer Institute.

[21]  A W Partin,et al.  Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.

[22]  A. Partin,et al.  Prostate-specific antigen after anatomic radical retropubic prostatectomy. Patterns of recurrence and cancer control. , 1997, The Urologic clinics of North America.

[23]  S. Yao,et al.  Population-based study of long-term survival in patients with clinically localised prostate cancer , 1997, The Lancet.

[24]  W. Hop,et al.  Tumour control according to pathological variables in patients treated by radical prostatectomy for clinically localized carcinoma of the prostate. , 1997, British journal of urology.

[25]  S. Fosså,et al.  Progression in untreated carcinoma of the prostate metastatic to regional lymph nodes (stage t0 to 4,N1 to 3.M0,D1). European Organization for Research and Treatment of Cancer Genitourinary Group. , 1995, The Journal of urology.

[26]  C Parkes,et al.  Prospective observational study to assess value of prostate specific antigen as screening test for prostate cancer , 1995, BMJ.

[27]  P. Boyle,et al.  Geographical and temporal patterns of incidence and mortality from prostate cancer. , 1995, Urology.

[28]  D. Fryback,et al.  Long-term survival among men with conservatively treated localized prostate cancer. , 1995, JAMA.

[29]  H. Neuwirth,et al.  Patterns of positive specimen margins and detectable prostate specific antigen after radical perineal prostatectomy. , 1995, The Journal of urology.

[30]  M. Stampfer,et al.  A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancer. , 1995, JAMA.

[31]  P. Knekt,et al.  Serum concentrations of prostate specific antigen and its complex with α1-antichymotrypsin before diagnosis of prostate cancer , 1994, The Lancet.

[32]  P. Scardino,et al.  Can radical prostatectomy alter the progression of poorly differentiated prostate cancer? , 1994, The Journal of urology.

[33]  T. Stamey,et al.  The pathological features and prognosis of prostate cancer detectable with current diagnostic tests. , 1994, The Journal of urology.

[34]  K. Pienta,et al.  Review of the role of androgenic hormones in the epidemiology of benign prostatic hyperplasia and prostate cancer. , 1994, Urology.

[35]  A. Partin,et al.  Radical prostatectomy for high grade disease: a reevaluation 1994. , 1994, The Journal of urology.

[36]  F. Schröder,et al.  Radical prostatectomy as a monotherapy for locally advanced (stage T3) prostate cancer. , 1994, The Journal of urology.

[37]  P. Walsh,et al.  Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer. , 1994, JAMA.

[38]  R. Thisted,et al.  Results of conservative management of clinically localized prostate cancer. , 1994, The New England journal of medicine.

[39]  M. Barry,et al.  Patient-re ported complications and follow-up treatment after radical prostatectomy , 1993 .

[40]  J. Oesterling,et al.  Using PSA to eliminate the staging radionuclide bone scan. Significant economic implications. , 1993, The Urologic clinics of North America.

[41]  J. Oesterling,et al.  Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade. , 1993, Urology.

[42]  E. Bergstralh,et al.  Long-term evaluation of radical prostatectomy as treatment for clinical stage C (T3) prostate cancer. , 1993, Urology.

[43]  V. E. Weldon,et al.  Potency-sparing radical perineal prostatectomy: anatomy, surgical technique and initial results. , 1987, The Journal of urology.

[44]  N. Breslow,et al.  Latent carcinoma of prostate at autopsy in seven areas. Collaborative study organized by the International Agency for Research on Cancer, Lyons, France , 1977, International journal of cancer.

[45]  G. Gray,et al.  The palpable nodule of prostatic cancer. Results 15 years after radical excision. , 1968, JAMA.

[46]  E. Belt.  Radical Perineal Prostatectomy in Early Carcinoma of the Prostate1 , 1942 .

[47]  J. Coebergh,et al.  Incidence of Cancer in the Netherlands 1998 , 2002 .

[48]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[49]  J. Epstein,et al.  Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. , 2001, Human pathology.

[50]  P. Schellhammer,et al.  Results of radical prostatectomy in men with locally advanced prostate cancer: multi-institutional pooled analysis. , 1997, European urology.

[51]  W. Catalona.  Patient selection for, results of, and impact on tumor resection of potency-sparing radical prostatectomy. , 1990, The Urologic clinics of North America.